Changes of T cell subsets across treatments associated with prognosis in newly diagnosed follicular lymphoma
Abstract Follicular lymphoma (FL) is an immune-responsive tumor with spontaneous remission. T cells play a pivotal role in the anti-lymphoma immune response. However, the dynamics of T cells during treatment, their impact on FL clinical outcomes, and the risk factors contributing to T-cell cytopenia...
Saved in:
| Main Authors: | Qiuhui Jiang, Feng Lin, Zhifeng Li, Hongpeng Duan, Chong Jiang, Xingxing Yu, Caiyan Wang, Li Zhang, Xiuhua Sun, Jie Zha, Long Liu, Zhijuan Lin, Bing Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-11-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-024-79173-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Achieving the cure of follicular lymphoma: is it time to finalize treatment strategies to reach this goal in a subset of patients?
by: Mauro Passucci, et al.
Published: (2023-02-01) -
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
by: Andrea Riccardo Filippi
Published: (2016-09-01) -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
by: Alessia Castellino, et al.
Published: (2017-01-01) -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS
by: Ugo Testa, et al.
Published: (2024-01-01) -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
by: Giuseppe Rossi, et al.
Published: (2016-11-01)